Vildagliptin and the Glucagon Response to Hypoglycemia in Insulin-Treated Patients With Type 2 Diabetes

NCT01219400 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Diabetes

Interventions

DRUG: Vildagliptin

Sponsor

Lund University